140 related articles for article (PubMed ID: 7850007)
21. Hexarelin, a synthetic GH-releasing peptide, is a powerful stimulus of GH secretion in pubertal children and in adults but not in prepubertal children and in elderly subjects.
Bellone J; Bartolotta E; Sgattoni C; Aimaretti G; Arvat E; Bellone S; Deghenghi R; Ghigo E
J Endocrinol Invest; 1998 Sep; 21(8):494-500. PubMed ID: 9801989
[TBL] [Abstract][Full Text] [Related]
22. Arginine stimulates growth hormone secretion by suppressing endogenous somatostatin secretion.
Alba-Roth J; Müller OA; Schopohl J; von Werder K
J Clin Endocrinol Metab; 1988 Dec; 67(6):1186-9. PubMed ID: 2903866
[TBL] [Abstract][Full Text] [Related]
23. Pyridostigmine partially restores the GH responsiveness to GHRH in normal aging.
Ghigo E; Goffi S; Arvat E; Nicolosi M; Procopio M; Bellone J; Imperiale E; Mazza E; Baracchi G; Camanni F
Acta Endocrinol (Copenh); 1990 Aug; 123(2):169-73. PubMed ID: 2220258
[TBL] [Abstract][Full Text] [Related]
24. Growth hormone-releasing activity of growth hormone-releasing peptide-6 is maintained after short-term oral pretreatment with the hexapeptide in normal aging.
Ghigo E; Arvat E; Rizzi G; Goffi S; Grottoli S; Mucci M; Boghen MF; Camanni F
Eur J Endocrinol; 1994 Nov; 131(5):499-503. PubMed ID: 7952160
[TBL] [Abstract][Full Text] [Related]
25. Arginine potentiates but does not restore the blunted growth hormone response to growth hormone-releasing hormone in obesity.
Ghigo E; Procopio M; Boffano GM; Arvat E; Valente F; Maccario M; Mazza E; Camanni F
Metabolism; 1992 May; 41(5):560-3. PubMed ID: 1588839
[TBL] [Abstract][Full Text] [Related]
26. In obesity the somatotrope response to either growth hormone-releasing hormone or arginine is inhibited by somatostatin or pirenzepine but not by glucose.
Maccario M; Procopio M; Grottoli S; Oleandri SE; Razzore P; Camanni F; Ghigo E
J Clin Endocrinol Metab; 1995 Dec; 80(12):3774-8. PubMed ID: 8530634
[TBL] [Abstract][Full Text] [Related]
27. Growth hormone-releasing effect of oral growth hormone-releasing peptide 6 (GHRP-6) administration in children with short stature.
Bellone J; Ghizzoni L; Aimaretti G; Volta C; Boghen MF; Bernasconi S; Ghigo E
Eur J Endocrinol; 1995 Oct; 133(4):425-9. PubMed ID: 7581965
[TBL] [Abstract][Full Text] [Related]
28. The decrease in growth hormone (GH) response after repeated stimulation with GH-releasing hormone is partly caused by an elevation of somatostatin tonus.
Reichardt B; Schrader M; Mojto J; Mehltretter G; Müller OA; Schopohl J
J Clin Endocrinol Metab; 1996 May; 81(5):1994-8. PubMed ID: 8626871
[TBL] [Abstract][Full Text] [Related]
29. Growth hormone (GH) profiles with successive provocation by GH-releasing hormone and arginine in children: a clinical appraisal.
Sato T; Igarashi N; Miyagawa K; Shimizu M; Nishikawa T
Endocrinol Jpn; 1991 Feb; 38(1):33-8. PubMed ID: 1915111
[TBL] [Abstract][Full Text] [Related]
30. Galanin reinstates the growth hormone response to repeated growth hormone-releasing hormone administration in man.
Arvat E; Ghigo E; Nicolosi M; Boffano GM; Bellone J; Yin-Zhang W; Mazza E; Camanni F
Clin Endocrinol (Oxf); 1992 Apr; 36(4):347-50. PubMed ID: 1385023
[TBL] [Abstract][Full Text] [Related]
31. Blunted GH response to growth hormone-releasing hormone (GHRH) alone or combined with arginine in non-insulin-dependent diabetes mellitus.
Martina V; Bruno G; Tagliabue M; Bertaina S; Maccario M; Grottoli S; Procopio M; Ozzello A; Camanni F
Horm Metab Res; 1995 Jan; 27(1):26-30. PubMed ID: 7729789
[TBL] [Abstract][Full Text] [Related]
32. A neuroendocrinological approach to evidence an impairment of central cholinergic function in aging.
Ghigo E; Goffi S; Arvat E; Imperiale E; Boffano GM; Valetto MR; Mazza E; Santi I; Magliona A; Boghen MF
J Endocrinol Invest; 1992 Oct; 15(9):665-70. PubMed ID: 1479149
[TBL] [Abstract][Full Text] [Related]
33. Effects of exogenous growth hormone pretreatment on the pituitary growth hormone response to growth hormone-releasing hormone alone or in combination with pyridostigmine in type I diabetic patients.
Giustina A; Bossoni S; Bodini C; Cimino A; Pizzocolo G; Schettino M; Wehrenberg WB
Acta Endocrinol (Copenh); 1991 Nov; 125(5):510-7. PubMed ID: 1759540
[TBL] [Abstract][Full Text] [Related]
34. Patients with dilated cardiomyopathy show reduction of the somatotroph responsiveness to GHRH both alone and combined with arginine.
Broglio F; Benso A; Gottero C; Vito LD; Aimaretti G; Fubini A; Arvat E; Bobbio M; Ghigo E
Eur J Endocrinol; 2000 Feb; 142(2):157-63. PubMed ID: 10664524
[TBL] [Abstract][Full Text] [Related]
35. Interaction of free fatty acids and arginine on growth hormone secretion in man.
Maccario M; Procopio M; Loche S; Cappa M; Martina V; Camanni F; Ghigo E
Metabolism; 1994 Feb; 43(2):223-6. PubMed ID: 8121306
[TBL] [Abstract][Full Text] [Related]
36. Corticotropin-releasing hormone inhibition of growth hormone-releasing hormone-induced growth hormone release in man.
Barbarino A; Corsello SM; Della Casa S; Tofani A; Sciuto R; Rota CA; Bollanti L; Barini A
J Clin Endocrinol Metab; 1990 Nov; 71(5):1368-74. PubMed ID: 2229294
[TBL] [Abstract][Full Text] [Related]
37. Arginine but not pyridostigmine, a cholinesterase inhibitor, enhances the GHRH-induced GH rise in patients with anorexia nervosa.
Ghigo E; Arvat E; Gianotti L; Nicolosi M; Valetto MR; Avagnina S; Bellitti D; Rolla M; Müller EE; Camanni F
Biol Psychiatry; 1994 Nov; 36(10):689-95. PubMed ID: 7880938
[TBL] [Abstract][Full Text] [Related]
38. Effect of digoxin on the somatotroph responsiveness to growth hormone-releasing hormone (GHRH) alone or combined with arginine in normal young volunteers.
Broglio F; Benso A; Gottero C; Vito LD; Granata R; Arvat E; Bobbio M; Trevi G; Ghigo E
Clin Endocrinol (Oxf); 2001 Dec; 55(6):755-8. PubMed ID: 11895217
[TBL] [Abstract][Full Text] [Related]
39. Effect of combined administration of growth hormone (GH)-releasing hormone, GH-releasing peptide-6, and pyridostigmine in normal and obese subjects.
Cordido F; Peñalva A; Peino R; Casanueva FF; Dieguez C
Metabolism; 1995 Jun; 44(6):745-8. PubMed ID: 7783658
[TBL] [Abstract][Full Text] [Related]
40. In obesity, glucose load loses its early inhibitory, but maintains its late stimulatory, effect on somatotrope secretion.
Grottoli S; Procopio M; Maccario M; Zini M; Oleandri SE; Tassone F; Valcavi R; Ghigo E
J Clin Endocrinol Metab; 1997 Jul; 82(7):2261-5. PubMed ID: 9215304
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
